Takeda Pharmaceutical Company Limited (TAK)

Takeda Pharmaceutical Stock Forecast

Stock Price Forecast

According to 3 analysts polled by S&P Global, Takeda Pharmaceutical stock has a consensus rating of "Strong Buy" and an average price target of $20.4. The average 1-year stock price forecast is 35.82% higher than the current stock price, while the lowest is $18.65 (+24.17%) and the highest is $21.78 (+45.01%).

Price Target: $20.4 (+35.82%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$18.65	$20.4	$20.77	$21.78
Change	+24.17%	+35.82%	+38.28%	+45.01%

* Price targets were last updated on Mar 31, 2026.

Analyst Ratings

The average analyst rating for Takeda Pharmaceutical stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Dec '25	Jan '26	Feb '26	Mar '26	Apr '26	May '26
Strong Buy	3	3	3	3	3	3
Buy	0	0	0	0	0	0
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	3	3	3	3	3	3

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Michael Nedelcovych TD Cowen	TD Cowen	Buy Maintains $21	Buy	Maintains	$21	+39.81%	Mar 31, 2026

Financial Forecast

Revenue This Year

4.62T

Increased by 2.43%

from 4.51T

Revenue Next Year

4.69T

Increased by 1.63%

from 4.62T

EPS This Year

136.06

Increased by 13.72%

from 119.64

EPS Next Year

197.11

Increased by 44.88%

from 136.06

Fiscal Year	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Mar 31, 2022	Mar 31, 2023	Mar 31, 2024	Mar 31, 2025	Mar 31, 2026	Mar 31, 2027
Revenue	3.57T	4.03T	4.26T	4.58T	4.51T	4.62T
Revenue Growth	11.61%	12.85%	5.87%	7.45%	-1.65%	2.43%
Gross Profit	2.44T	2.77T	2.83T	3.01T	2.93T	3.01T
Gross Margin	68.41%	68.88%	66.43%	65.70%	65.12%	65.30%
Operating Income	600.06B	619.67B	499.48B	562.94B	625.28B	499.59B
Net Income	230.06B	317.02B	144.07B	107.93B	191.76B	207.13B
EPS	145.87	201.94	91.16	67.23	119.64	136.06
EPS Growth	-38.96%	38.44%	-54.86%	-26.25%	77.96%	13.72%
Forward PE	-	-	-	-	-	17.66
Dividend / Share	180.00	180.00	188.00	196.00	200.00	204.85
Dividend Growth	-	-	4.44%	4.26%	2.04%	2.42%
Free Cash Flow	929.11B	480.30B	119.41B	735.62B	356.63B	835.38B
No. Analysts	-	-	-	-	-	13

Financial currency is JPY.

Revenue Forecast

Revenue	2027	2028	2029
High	4.7T
Avg	4.6T
Low	4.5T

Revenue Growth

Revenue Growth	2027	2028	2029
High	5.3%
Avg	2.4%
Low	-0.4%

EPS Forecast

EPS	2027	2028	2029
High	188.50
Avg	136.06
Low	102.00

EPS Growth

EPS Growth	2027	2028	2029
High	57.6%
Avg	13.7%
Low	-14.7%

Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by TipRanks. Financial forecast data provided by S&P Global Market Intelligence. The data is sourced from Wall Street analysts. Data sources.